MTCH2调节NRF2介导的RRM1表达,促进黑色素瘤扩散和达卡巴辛不敏感性
Xuedan Zhang1, Enjiang Li1, Yingmin Kuang2
1Department of Biochemistry and Molecular Biology, School of Basic Medicine, Kunming Medical University, Kunming, 650500, Yunnan, China.
Cell death & disease
|April 9, 2025
概括
这项研究揭示了线粒体载体同源2 (MTCH2) 通过激活NRF2-RRM1通路来驱动黑色素瘤生长. 在临床前模型中,用达卡巴辛向RRM1有效抑制瘤进展.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 黑色素瘤是一个重大的健康威胁,需要对其分子驱动因素有更深入的了解.
- 识别黑色素瘤扩散的关键调节因子对于开发有效疗法至关重要.
研究的目的:
- 为了确定黑色素瘤扩散的新型分子调节剂.
- 阐明MTCH2在黑色素瘤进展中的机制性作用.
- 在已识别的途径中探索潜在的治疗点.
主要方法:
- 生物信息分析用于识别关键基因.
- 在黑色素瘤细胞中实验验证MTCH2功能.
- 对NRF2-RRM1通路激活的评估.
- 在体内异种移植模型来评估治疗疗效.
主要成果:
- 线粒体载体同位素2 (MTCH2) 被确定为黑色素瘤扩散的关键促进者.
- MTCH2上调节核因子 (红色素衍生-2) - - 类似的2 (NRF2) 和核酸还原酶子单元M1 (RRM1) 的表达.
- 在RRM1和达卡巴辛的联合向在体内显著抑制了黑色素瘤瘤的生长.
结论:
- 通过NRF2-RRM1信号轴,MTCH2在黑色素瘤扩散中发挥着关键作用.
- MTCH2-NRF2-RRM1通路代表了黑色素瘤治疗的有前途的治疗标.
- 针对RRM1的组合疗法显示出显著的抗瘤活性.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
MAPK Signaling Cascades
5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K


